List With HCPCS Codes For Anti-Inflammatory Medication and Chemotherapy Medication

The HCPCS codes for Anti-Inflammatory Medication and Chemotherapy Medication range from Q5103 to Q5111. These codes represent various injections of biosimilar medications used for treating inflammatory conditions and chemotherapy.

1. HCPCS Code Q5103

HCPCS Q5103 describes the injection of infliximab-dyyb, a biosimilar medication called Inflectra, which is used to treat inflammatory conditions.

2. HCPCS Code Q5104

HCPCS Q5104 describes the injection of infliximab-abda, a biosimilar medication called Renflexis, which is used to treat inflammatory conditions.

3. HCPCS Code Q5105

HCPCS Q5105 describes the injection of epoetin alfa-epbx, a biosimilar medication called Retacrit, which is used for erythropoiesis-stimulating therapy in patients with end-stage renal disease on dialysis.

4. HCPCS Code Q5106

HCPCS Q5106 describes the injection of epoetin alfa-epbx, a biosimilar medication called Retacrit, which is used for erythropoiesis-stimulating therapy in patients with non-end-stage renal disease.

5. HCPCS Code Q5107

HCPCS Q5107 describes the injection of bevacizumab-awwb, a biosimilar medication called Mvasi, which is used for chemotherapy treatment.

6. HCPCS Code Q5108

HCPCS Q5108 describes the injection of pegfilgrastim-jmdb, a biosimilar medication called Fulphila, which is used to stimulate the production of white blood cells in patients undergoing chemotherapy.

7. HCPCS Code Q5109

HCPCS Q5109 describes the injection of infliximab-qbtx, a biosimilar medication called Ixifi, which is used to treat inflammatory conditions.

8. HCPCS Code Q5110

HCPCS Q5110 describes the injection of filgrastim-aafi, a biosimilar medication called Nivestym, which is used to stimulate the production of white blood cells in patients undergoing chemotherapy.

9. HCPCS Code Q5111

HCPCS Q5111 describes the injection of pegfilgrastim-cbqv, a biosimilar medication called Udenyca, which is used to stimulate the production of white blood cells in patients undergoing chemotherapy.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *